Terms: = Brain cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Diagnosis
39 results:
1. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
2. Metastatic profiles and survival differences between infiltrating ductal carcinoma and infiltrating lobular carcinoma in invasive breast cancer.
Cavaller L; Goupille C; Arbion F; Vilde A; Body G; Ouldamer L
J Gynecol Obstet Hum Reprod; 2024 Apr; 53(4):102740. PubMed ID: 38311000
[TBL] [Abstract] [Full Text] [Related]
3. Association of State Medicaid Income Eligibility Limits and Long-Term Survival After cancer diagnosis in the United States.
Zhao J; Han X; Nogueira L; Hyun N; Jemal A; Yabroff KR
JCO Oncol Pract; 2022 Jun; 18(6):e988-e999. PubMed ID: 34995127
[TBL] [Abstract] [Full Text] [Related]
4. Advantage of high b value diffusion-weighted imaging for differentiation of common pediatric brain tumors in posterior fossa.
Takeishi Y; Takayasu T; Kolakshyapati M; Yonezawa U; Amatya VJ; Takano M; Taguchi A; Takeshima Y; Sugiyama K; Kurisu K; Yamasaki F
Eur J Radiol; 2020 Jul; 128():108983. PubMed ID: 32438259
[TBL] [Abstract] [Full Text] [Related]
5. Association of Protein Expression and Methylation of DAPK1 with Clinicopathological Features in Invasive Ductal Carcinoma Patients from Kashmir.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Zargar MA
Asian Pac J Cancer Prev; 2019 Mar; 20(3):839-848. PubMed ID: 30912402
[TBL] [Abstract] [Full Text] [Related]
6. Occupational exposure to high-frequency electromagnetic fields and brain tumor risk in the INTEROCC study: An individualized assessment approach.
Vila J; Turner MC; Gracia-Lavedan E; Figuerola J; Bowman JD; Kincl L; Richardson L; Benke G; Hours M; Krewski D; McLean D; Parent ME; Sadetzki S; Schlaefer K; Schlehofer B; Schüz J; Siemiatycki J; van Tongeren M; Cardis E;
Environ Int; 2018 Oct; 119():353-365. PubMed ID: 29996112
[TBL] [Abstract] [Full Text] [Related]
7. Advantages of high b-value diffusion-weighted imaging for preoperative differential diagnosis between embryonal and ependymal tumors at 3 T MRI.
Takayasu T; Yamasaki F; Akiyama Y; Ohtaki M; Saito T; Nosaka R; Takano M; Sugiyama K; Kurisu K
Eur J Radiol; 2018 Apr; 101():136-143. PubMed ID: 29571787
[TBL] [Abstract] [Full Text] [Related]
8. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
[TBL] [Abstract] [Full Text] [Related]
9. Advantage of High b Value Diffusion-Weighted Imaging for Differentiation of Hemangioblastoma from brain Metastases in Posterior Fossa.
Onishi S; Hirose T; Takayasu T; Nosaka R; Kolakshyapati M; Saito T; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
World Neurosurg; 2017 May; 101():643-650. PubMed ID: 28179177
[TBL] [Abstract] [Full Text] [Related]
10. Combining random forest and 2D correlation analysis to identify serum spectral signatures for neuro-oncology.
Smith BR; Ashton KM; Brodbelt A; Dawson T; Jenkinson MD; Hunt NT; Palmer DS; Baker MJ
Analyst; 2016 Jun; 141(12):3668-78. PubMed ID: 26818218
[TBL] [Abstract] [Full Text] [Related]
11. Diffusion-weighted imaging and the apparent diffusion coefficient on 3T MR imaging in the differentiation of craniopharyngiomas and germ cell tumors.
Kinoshita Y; Yamasaki F; Tominaga A; Ohtaki M; Usui S; Arita K; Sugiyama K; Kurisu K
Neurosurg Rev; 2016 Apr; 39(2):207-13; discussion 213. PubMed ID: 26280640
[TBL] [Abstract] [Full Text] [Related]
12. The role of CT body scans in the investigation of patients with newly diagnosed brain tumours.
Bailey M; Qureshi A; Kamaly-Asl I
Br J Neurosurg; 2014 Jun; 28(3):347-50. PubMed ID: 24111709
[TBL] [Abstract] [Full Text] [Related]
13. "A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies".
Marsden CG; Wright MJ; Carrier L; Moroz K; Pochampally R; Rowan BG
BMC Cancer; 2012 Jan; 12():10. PubMed ID: 22233382
[TBL] [Abstract] [Full Text] [Related]
14. Advantages of high b-value diffusion-weighted imaging to diagnose pseudo-responses in patients with recurrent glioma after bevacizumab treatment.
Yamasaki F; Kurisu K; Aoki T; Yamanaka M; Kajiwara Y; Watanabe Y; Takayasu T; Akiyama Y; Sugiyama K
Eur J Radiol; 2012 Oct; 81(10):2805-10. PubMed ID: 22100373
[TBL] [Abstract] [Full Text] [Related]
15. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
[TBL] [Abstract] [Full Text] [Related]
16. Pulmonary metastases revealing choriocarcinoma.
El Fekih L; Hassene H; Fenniche S; Ben Abdelghaffar H; Belhabib D; Megdiche ML
Tunis Med; 2010 Jan; 88(1):49-51. PubMed ID: 20415215
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy and safety of levetiracetam in patients with glioma: a clinical prospective study.
Rosati A; Buttolo L; Stefini R; Todeschini A; Cenzato M; Padovani A
Arch Neurol; 2010 Mar; 67(3):343-6. PubMed ID: 20212232
[TBL] [Abstract] [Full Text] [Related]
18. Acridinium ester conjugated to lectin as chemiluminescent histochemistry marker.
Campos LM; Cavalcanti CL; Lima-Filho JL; Carvalho LB; Beltrão EI
Biomarkers; 2006; 11(5):480-4. PubMed ID: 16966164
[TBL] [Abstract] [Full Text] [Related]
19. Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiation.
Shien T; Tashiro T; Omatsu M; Masuda T; Furuta K; Sato N; Akashi-Tanaka S; Uehara M; Iwamoto E; Kinoshita T; Fukutomi T; Tsuda H; Hasegawa T
J Clin Pathol; 2005 Dec; 58(12):1299-304. PubMed ID: 16311351
[TBL] [Abstract] [Full Text] [Related]
20. Minimally invasive approaches to treat simultaneous occurrence of glioblastoma multiforme and intracranial aneurysm -- case report.
Cheng WY; Shen CC
Minim Invasive Neurosurg; 2004 Jun; 47(3):181-5. PubMed ID: 15343437
[TBL] [Abstract] [Full Text] [Related]
[Next]
